Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia

Daniel Casey

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Neuroleptic drug-induced acute extrapyramidal symptoms and later-onset tardive dyskinesia are major limitations to these valuable drugs. Each of these disorders can be described by special risk factors that include patient characteristics, drug factors, and temporal considerations. The limitations that derive from these motor side effects have been one of the major reasons propelling the search for neuroleptic drugs that are free of these side effects. Strategies for managing the acute and late-onset extrapyramidal syndromes are presented. Significantly more research is needed, however, on all these disorders before a unified and cohesive explanation can account for these seemingly disparate syndromes. New medications, which effectively treat schizophrenia and are free of acute extrapyramidal syndromes and tardive dyskinesia, will be a giant step forward in patient care and our knowledge of the mechanisms controlling both mental function and motor control.

Original languageEnglish (US)
Pages (from-to)589-610
Number of pages22
JournalPsychiatric Clinics of North America
Volume16
Issue number3
StatePublished - 1993
Externally publishedYes

Fingerprint

Antipsychotic Agents
Drug-Related Side Effects and Adverse Reactions
Pharmaceutical Preparations
Schizophrenia
Patient Care
Research
Tardive Dyskinesia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. / Casey, Daniel.

In: Psychiatric Clinics of North America, Vol. 16, No. 3, 1993, p. 589-610.

Research output: Contribution to journalArticle

@article{be7b3902bd434cf3834e6a95b2cb67ef,
title = "Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia",
abstract = "Neuroleptic drug-induced acute extrapyramidal symptoms and later-onset tardive dyskinesia are major limitations to these valuable drugs. Each of these disorders can be described by special risk factors that include patient characteristics, drug factors, and temporal considerations. The limitations that derive from these motor side effects have been one of the major reasons propelling the search for neuroleptic drugs that are free of these side effects. Strategies for managing the acute and late-onset extrapyramidal syndromes are presented. Significantly more research is needed, however, on all these disorders before a unified and cohesive explanation can account for these seemingly disparate syndromes. New medications, which effectively treat schizophrenia and are free of acute extrapyramidal syndromes and tardive dyskinesia, will be a giant step forward in patient care and our knowledge of the mechanisms controlling both mental function and motor control.",
author = "Daniel Casey",
year = "1993",
language = "English (US)",
volume = "16",
pages = "589--610",
journal = "Psychiatric Clinics of North America",
issn = "0193-953X",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia

AU - Casey, Daniel

PY - 1993

Y1 - 1993

N2 - Neuroleptic drug-induced acute extrapyramidal symptoms and later-onset tardive dyskinesia are major limitations to these valuable drugs. Each of these disorders can be described by special risk factors that include patient characteristics, drug factors, and temporal considerations. The limitations that derive from these motor side effects have been one of the major reasons propelling the search for neuroleptic drugs that are free of these side effects. Strategies for managing the acute and late-onset extrapyramidal syndromes are presented. Significantly more research is needed, however, on all these disorders before a unified and cohesive explanation can account for these seemingly disparate syndromes. New medications, which effectively treat schizophrenia and are free of acute extrapyramidal syndromes and tardive dyskinesia, will be a giant step forward in patient care and our knowledge of the mechanisms controlling both mental function and motor control.

AB - Neuroleptic drug-induced acute extrapyramidal symptoms and later-onset tardive dyskinesia are major limitations to these valuable drugs. Each of these disorders can be described by special risk factors that include patient characteristics, drug factors, and temporal considerations. The limitations that derive from these motor side effects have been one of the major reasons propelling the search for neuroleptic drugs that are free of these side effects. Strategies for managing the acute and late-onset extrapyramidal syndromes are presented. Significantly more research is needed, however, on all these disorders before a unified and cohesive explanation can account for these seemingly disparate syndromes. New medications, which effectively treat schizophrenia and are free of acute extrapyramidal syndromes and tardive dyskinesia, will be a giant step forward in patient care and our knowledge of the mechanisms controlling both mental function and motor control.

UR - http://www.scopus.com/inward/record.url?scp=0027217959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027217959&partnerID=8YFLogxK

M3 - Article

C2 - 8105453

AN - SCOPUS:0027217959

VL - 16

SP - 589

EP - 610

JO - Psychiatric Clinics of North America

JF - Psychiatric Clinics of North America

SN - 0193-953X

IS - 3

ER -